Pentagalloylglucose, a limited oral bioavailability polyphenol, improves allergic asthma through regulating gut microbiota and modulating enteritis
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.70345 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Xia'nan Sang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Asthma, Hydrolyzable Tannins, Gastrointestinal Microbiome, Anti-Asthmatic Agents. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Research Project of Zhejiang Chinese Medical University.
Abstract (Originalsprache)
Background and Purpose Pentagalloylglucose (PGG), a natural hydrolysable gall tannin, has limited bioavailability, and its biological activities are concentrated in the digestive system. However, our study discovered that this nonabsorbable compound can improve allergic asthma. This study focuses on elucidating the mechanisms underlying PGG's anti‐allergic asthma effects. Methods PGG serum metabolites were analyzed by UPLC/Q‐TOF MS. To further explore its mechanisms, 16S rRNA sequencing, qPCR, and UPLC/Q‐TOF MS were used to assess gut microbiota and metabolites. Fecal microbiota transplantation from PGG‐treated mice into antibiotic‐treated asthmatic mice evaluated its microbiota‐dependent effects. Flow cytometry analyzed PGG's modulation of pulmonary ILC2s in a murine asthma‑colitis comorbid model. Key Results PGG's serum metabolites were below the quantification limit. PGG administration improved colonic injury and modulated L. reuteri ; notably, exogenous L. reuteri alleviated asthma via increasing I3A from Trp metabolism. However, fecal microbiota transplantation from PGG‐treated mice did not alleviate asthma, and PGG remained effective in microbiota‐depleted mice, suggesting its action is microbiota‐independent. Furthermore, PGG alleviated intestinal inflammation in both normal and antibiotic‐treated asthmatic mice. In a comorbid colitis‐asthma model, PGG counteracted colitis‐aggravated asthma symptoms by modulating lung ILC2s. Conclusion and Implications Although PGG modulates the gut microbiota and related metabolites, its anti‐asthmatic effect is not primarily dependent on this pathway. Notably, it can ameliorate lung ILC2 dysregulation by alleviating enteritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Research Project of Zhejiang Chinese Medical University
- Students Science and Technology Innovation Activity Plan of Zhejiang Province
Zitieren
APA
Sang, X., Zheng, Q., Qin, M., Chen, M., Wan, X., Hao, M., Yang, Q., & Cao, G. (2026). Pentagalloylglucose, a limited oral bioavailability polyphenol, improves allergic asthma through regulating gut microbiota and modulating enteritis. British Journal of Pharmacology. https://doi.org/10.1111/bph.70345
Vancouver
Sang X, Zheng Q, Qin M, Chen M, Wan X, Hao M, et al. Pentagalloylglucose, a limited oral bioavailability polyphenol, improves allergic asthma through regulating gut microbiota and modulating enteritis. British Journal of Pharmacology. 2026. doi:10.1111/bph.70345
BibTeX
@article{Sang2026,
author = {Sang, Xia'nan and Zheng, Qitong and Qin, Minjing and Chen, Mengyao and Wan, Xuedong and Hao, Min and Yang, Qiao and Cao, Gang},
title = {Pentagalloylglucose, a limited oral bioavailability polyphenol, improves allergic asthma through regulating gut microbiota and modulating enteritis},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70345}
}
EUVIMED